Febuxostat Therapy for Patients with Gout and Stage 2-4 CKD: a Retrospective Study.
Peiyu ZhangMo ChenJundi WangShunjie HuXiaoyong LuHuaxiang WuPublished in: Rheumatology and therapy (2022)
Febuxostat demonstrated efficacy and renal safety in patients with gout and CKD in clinical practice. Achieving the target SU could obviously improve renal function. Baseline SU level and body weight could affect the achievement of target SU.